The Inflation Reduction Act of 2022 will add 87,000 new IRS employees at a cost of $80 billion in potentially wasteful spending.
The House Should Avoid Making the Senate’s Terrible Mistake on Healthcare
The House should avoid making the mistake of cutting the number of future cures and raising healthcare costs.
The Inflation Reduction Act Will Raise Drug Costs and Reduce Cures
Price controls in the Inflation Reduction Act will devastate future drug development and raise costs.
Spectrum Coordination Needs to Expand Across More Federal Agencies
The FCC and NTIA announced signing an MOU on spectrum allocation coordination. Other federal agencies should join this effort.
The Inflation Reduction Act Is a Fiscal Disaster
The Inflation Reduction Act of 2022 will raise taxes, increase spending, and prolong both inflation and the recession.
Senators Need to Check Their Conscience Before Voting for Price Controls
Senators must understand that price controls will harm patients and reduce the development of future cures.
Subcommittee Hearing Tries to Shed Light on COVID-19 Relief Fraud
The government’s abject failure to prevent COVID fraud shows the risks of hasty and reckless spending.
The IRS Continues to Fall Short on its Mission
Government agencies serve the people, and the IRS has continually fallen short in achieving this mission.
Stimulus Checks Will Make Inflation Worse, Not Better
Pumping more money into the economy will add to inflation and do more harm in the long term.
The Human Cost of Pharmaceutical Price Controls is Too High
Price controls will result in the loss of life due to a lack of future research and development.